Bioactive Compounds
-
BA2265 PF-00835231Summary: PF-00835231 is an inhibitor of a major viral protease. -
BA2263 MerafloxacinSummary: Merafloxacin (CI-934), a fluoroquinolone antimicrobial agent, is a selective programmed-1 ribosome translocation inhibitor of beta viruses. -
BA2262 LP-935509Summary: LP-935509 is an orally potent, selective, ATP-competitive, and blood-brain barrier-crossing inhibitor of junctional protein-2-related kinase 1. -
BA2259 EnsitrelvirSummary: Ensitrelvir (S-217622) is the first to be orally active. -
BA2258 ZotatifinSummary: Zotatifin (eFT226) is a potent, selective and well-tolerated eIF4A inhibitor. -
BA2257 GSK3326595Summary: GSK3326595 is a protein arginine methyltransferase 5 inhibitor. -
BA2256 PaquinimodSummary: Paquinimod (ABR215757) is a specific inhibitor with oral activity. -
BA2254 RSV-IN-1Summary: RSV-IN-1 is an inhibitor of human respiratory syncytial virus. -
BA2252 BMS-433771Summary: BMS-433771 is a potent respiratory syncytial virus (RSV) inhibitor with oral activity. -
BA2251 EnzaplatovirSummary: Enzaplatovir (BTA-C585) is an orally effective fusion inhibitor.

